Is EyePoint Inc halal to invest in?

According to Musaffa's Shariah screening methodology, EyePoint Inc (EYPT) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is EyePoint Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes EyePoint Inc using these criteria to determine its compliance status.

Can Muslims buy shares of EyePoint Inc?

Muslim investors may consider investing in EyePoint Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is EyePoint Inc classified as NOT HALAL?

Musaffa determines the Shariah status of EyePoint Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for EyePoint Inc updated?

The Shariah compliance status of EyePoint Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like EyePoint Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of EyePoint Inc?

You can check the latest Shariah compliance status of EyePoint Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

EYPT Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: March 10, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for EyePoint Inc (EYPT)

Based on 18 analysts giving stock ratings to EyePoint Inc in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

EyePoint Inc. Stock Analysis EYPT

United States Health Care Small Cap Report: 2025 Annual

EyePoint Plc is a biopharmaceutical company, which engages in the development and commercialization of therapeutics that treat eye disorders. The company is headquartered in Watertown, Massachusetts and currently employs 214 full-time employees. The company went IPO on 2005-01-27. The firm is focused on developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The Company’s lead product candidate, DURAVYU, is an investigational-sustained delivery treatment for serious retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor, with bioerodible Durasert E technology. Vorolanib features a novel multi-mechanism of action as it targets both vascular endothelial growth factor (VEGF)-mediated vascular permeability and IL-6 mediated inflammation through inhibition of all VEGF receptors and pro-inflammatory IL-6/JAK1 signaling. DURAVYU is in Phase III pivotal trials for wet age-related macular degeneration. DURAVYU is also being advanced for the treatment of diabetic macular edema (DME) with the first patient dosing in Phase III trials.

Key Statistics of EyePoint Inc (EYPT)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$12.33$13.11

Today's Open

$13.04

Volume

538.88K

P/E Ratio (TTM)

52 Week Range

$5.35$19.11

Market Cap

1.15B

Avg. Volume

847.30K

Dividend Yield

Financial Metrics & Statements of EyePoint Inc (EYPT)

FAQ's for EyePoint Inc (EYPT)

According to Musaffa’s Shariah screening methodology, EyePoint Inc (EYPT) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.